Mirum Pharmaceuticals, Inc. Common Stock MIRM
$101.50
+1.91%
at last close
Financials (TTM)
- Revenue
- $569.61 million
- Net Income
- $-798,841,000
- Net Margin
- -140.24%
- Return on Equity
- -329.43%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 25.05
- Price / Sales
- 10.66
Over the trailing twelve months, Mirum Pharmaceuticals, Inc. Common Stock generated revenue of $569.61 million and net income of $-798,841,000, a net margin of -140.24%.
At the last closing price of $101.50, MIRM trades at 10.66 times sales, with a market capitalization of $6.07 billion.
Key Stats
- Last Close
- $101.50
- Market Cap
- $6.07 billion
- 52-Week Range
- $39.84 – $114.99
- Average Volume
- 1.08 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.